Discovering Common Pathogenic Mechanisms of COVID-19 and Parkinson Disease: An Integrated Bioinformatics Analysis

Area of Science:

• Genomics and Molecular Biology
• Neuroscience
• Immunology

Background:

• Coronavirus disease 2019 (COVID-19) is a global pandemic with potential neurological implications.
• The association between COVID-19 and Parkinson's disease (PD) remains unclear, with several hypotheses proposed.
• Understanding shared biological mechanisms is crucial for elucidating this link.

Purpose of the Study:

• To identify common molecular signatures between COVID-19 and Parkinson's disease (PD).
• To explore potential biological pathways and regulatory elements connecting these two conditions.
• To provide novel insights into the pathogenesis of PD influenced by viral infections.

Main Methods:

• Analysis of transcriptome data from peripheral blood mononuclear cells (PBMCs) of COVID-19 and PD patients.
• Identification of common differentially expressed genes (DEGs) and construction of protein-protein interaction networks (PPINs).
• Functional enrichment analysis, hub gene detection, and investigation of regulatory transcription factors and miRNAs.

Main Results:

• Identified 81 common DEGs between COVID-19 and PD patients.
• Functional enrichment revealed involvement in complement system, IFNG signaling, oxidative damage, and microglial pathways.
• Discovered 10 hub genes (e.g., MX1, IFI27, C1QC) linked to inflammation, microglia activation, and cytokine storm, regulated by transcription factors like SOX2 and RUNX1.

Conclusions:

• Common biological pathways and molecular mechanisms may link COVID-19 and Parkinson's disease.
• Hub genes and their regulatory networks offer potential therapeutic targets for PD.
• This research provides a molecular basis for understanding the neurological sequelae of COVID-19 in relation to PD.